Early research (Phase 1)Ended earlyNCT02931110What this trial is testingStudy of IV CBL0137 in Previously Treated Hematological SubjectsWho this might be right forHematological Malignancies Incuron 5
Early research (Phase 1)Study completedNCT00002818What this trial is testingHigh-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic MalignanciesWho this might be right forDrug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more Virginia Commonwealth University 15
Testing effectiveness (Phase 2)Study completedNCT00002809What this trial is testingBone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Temple University 10
Testing effectiveness (Phase 2)Study completedNCT02793544What this trial is testingHLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation CyclophosphamideWho this might be right forMyelodysplastic Syndrome (MDS)Chronic Lymphocytic Leukemia (CLL)Chemotherapy-sensitive Lymphoma+4 more Center for International Blood and Marrow Transplant Research 80
Early research (Phase 1)Looking for participantsNCT07573111What this trial is testingStudy of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationWho this might be right forAcute LeukemiaMyelodysplastic Syndrome Laguna Biotherapeutics, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00057811What this trial is testingRituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or LymphomaWho this might be right forChildhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell Lymphoma+9 more Children's Oncology Group 97
Post-approval studies (Phase 4)Ended earlyNCT04506086What this trial is testingFeasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forB-precursor Acute Lymphoblastic Leukemia Amgen 10
Testing effectiveness (Phase 2)Ended earlyNCT03615105What this trial is testingDonor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched DonorsWho this might be right forAcute Lymphoid Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)+3 more Memorial Sloan Kettering Cancer Center 9
Early research (Phase 1)Study completedNCT03263637What this trial is testingStudy to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological MalignanciesWho this might be right forRelapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more AstraZeneca 44
Testing effectiveness (Phase 2)Study completedNCT02614066What this trial is testingA Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)Who this might be right forRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Kite, A Gilead Company 125
Testing effectiveness (Phase 2)Study completedNCT00004105What this trial is testingCombination Chemotherapy in Treating Patients With Advanced CancerWho this might be right forLeukemiaLymphomaSarcoma+1 more NYU Langone Health
Very early researchUnknownNCT05651191What this trial is testingTo Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Hrain Biotechnology Co., Ltd. 9
Not applicableUnknownNCT01653613What this trial is testingStudying Genes in Samples From Younger Patients With Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Eastern Cooperative Oncology Group 400
Testing effectiveness (Phase 2)Looking for participantsNCT06886074What this trial is testingEfficacy of Short-course Blinatumomab for MRD Erradication in B-ALLWho this might be right forAcute Lymphoblastic LeukemiaMeasurable Residual Disease (MRD) Hospital Universitario Dr. Jose E. Gonzalez 30
Early research (Phase 1)Looking for participantsNCT06034275What this trial is testingStudy of VIP943 in Subjects With Advanced CD123+ Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaHigh-risk Myelodysplastic Syndrome Vincerx Pharma, Inc. 36
Not applicableActive Not RecruitingNCT07238907What this trial is testingA Multi-center Retrospective Study of INO Treating B-ALLWho this might be right forAcute Lymphoblastic LeukaemiaAcute Lymphoblastic Leukaemias (ALL)Inotuzumab Ozogamicin+1 more Ruijin Hospital 102
Large-scale testing (Phase 3)Active Not RecruitingNCT04530565What this trial is testingTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsWho this might be right forB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 National Cancer Institute (NCI) 348
Early research (Phase 1)Looking for participantsNCT07246707What this trial is testingKSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic LeukemiaWho this might be right forB-ALL Zhejiang University 30
Early research (Phase 1)Active Not RecruitingNCT02146924What this trial is testingCellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaRecurrent Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia City of Hope Medical Center 71
Early research (Phase 1)Study completedNCT00003082What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more University of Arizona 27